Longmen Capital

Longmen Capital operates as a specialized venture capital and private equity firm, dedicating its investment activities to the medical and pharmaceutical sectors. The firm focuses on identifying and supporting innovative medicine research and early-stage enterprises within the healthcare industry. Its strategic approach leverages deep industry expertise to foster growth in emerging biotech and medical technology companies.

The firm was established in 2017, originating in China with primary offices in Shenzhen and Zhuhai. It was founded on the insight that the medical and biological backgrounds of its team members, combined with extensive industry experience, would provide a distinct advantage in evaluating and nurturing promising ventures in the complex healthcare landscape. This specialized expertise underpins their investment thesis.

Longmen Capital primarily serves nascent and developing companies within the medical and pharmaceutical spaces, providing capital and strategic guidance to aid their expansion. The firm's long-term vision centers on contributing to advancements in healthcare by backing pioneering research and development, aiming to propel the next generation of medical solutions from concept to commercialization.